Becoming A Biopharma CEO During Pandemic Lockdowns
Source: Life Science Leader
In this snippet from an executive virtual roundtable, Marcio Souza, CEO of Praxis Precision Medicines, discusses how he became CEO of Praxis during a pandemic and how he soon thereafter took the company public.
This website uses cookies to ensure you get the best experience on our website. Learn more